APA (7th ed.) Citation

Zhao, Z., Zhang, X., Zhan, Y., Zuo, Y., Li, J., Ren, J., . . . Nie, Z. Selinexor combination with decitabine and half-dose CMG (Cytarabine+ Mitoxantrone+G-CSF) in Patients with refractory/relapsed acute myeloid leukemia (AML) previously exposed to Venetoclax: A single-center retrospective study. Elsevier.

Chicago Style (17th ed.) Citation

Zhao, Zi-Yu, Xiao-Lei Zhang, Ying Zhan, Ya-Bei Zuo, Jin-Ao Li, Jin-Hai Ren, Xiao-Ling Guo, and Zi-Yuan Nie. Selinexor Combination with Decitabine and Half-dose CMG (Cytarabine+ Mitoxantrone+G-CSF) in Patients with Refractory/relapsed Acute Myeloid Leukemia (AML) Previously Exposed to Venetoclax: A Single-center Retrospective Study. Elsevier.

MLA (9th ed.) Citation

Zhao, Zi-Yu, et al. Selinexor Combination with Decitabine and Half-dose CMG (Cytarabine+ Mitoxantrone+G-CSF) in Patients with Refractory/relapsed Acute Myeloid Leukemia (AML) Previously Exposed to Venetoclax: A Single-center Retrospective Study. Elsevier.